5/14/2013 8:15:12 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the first quarter ended March 31, 2013.
"Following our successful initial public offering in March 2013, Tetraphase is well positioned to advance our lead candidate eravacycline for the treatment of multi-drug resistant infections, particularly difficult-to-treat serious and life-threatening Gram-negative infections, that represent a potential global health crisis," said Guy Macdonald, Tetraphase President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by